Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Non Operating Investment Income (2022)

Aethlon Medical filings provide 1 years of Non Operating Investment Income readings, the most recent being -$142121.0 for Q3 2022.

  • On a quarterly basis, Non Operating Investment Income changed N/A to -$142121.0 in Q3 2022 year-over-year; TTM through Sep 2023 was -$142121.0, a 0.0% change, with the full-year FY2023 number at -$142121.0, changed N/A from a year prior.
  • Non Operating Investment Income hit -$142121.0 in Q3 2022 for Aethlon Medical.
  • In the past five years, Non Operating Investment Income ranged from a high of -$142121.0 in Q3 2022 to a low of -$142121.0 in Q3 2022.